Monogram Orthopaedics, Inc., headquartered in Brooklyn, New York, specializes in marketing orthopedic implants using a navigated robot for precision insertion, based on patient-specific plans from CT scans. The company, which employs 27 people and went public on 2023-05-18, aims to produce and market robotic surgical equipment and related orthopedic tools.
Monogram Orthopaedics (MGRM) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Monogram Orthopaedics's actual EPS was -$0.11, missing the estimate of -$0.09 per share, resulting in a -19.83% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
